Education
About Us
Working with TipRanks
Follow Us
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
Total Valuation
Pasithea Therapeutics Corp has a market cap or net worth of $7.12M. The enterprise value is ―.
Market Cap$7.12M
Enterprise Value―
Share Statistics
Pasithea Therapeutics Corp has 7,443,577 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,443,577
Owned by Insiders0.72%
Owned by Institutions0.95%
Financial Efficiency
Pasithea Therapeutics Corp’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -95.35%.
Return on Equity (ROE)-0.94
Return on Assets (ROA)-0.87
Return on Invested Capital (ROIC)-95.35%
Return on Capital Employed (ROCE)-0.95
Revenue Per Employee0.00
Profits Per Employee-3.48B
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pasithea Therapeutics Corp is >-0.01. Pasithea Therapeutics Corp’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio0.10
Price to Fair Value<0.01
Price to FCF-0.12
Price to Operating Cash Flow-0.11
PEG Ratio>-0.01
Income Statement
In the last 12 months, Pasithea Therapeutics Corp had revenue of 0.00 and earned -13.90B in profits. Earnings per share was -12.69K.
Revenue0.00
Gross Profit0.00
Operating Income-14.25B
Pretax Income-13.90B
Net Income-13.90B
EBITDA-14.25B
Earnings Per Share (EPS)-12.69K
Cash Flow
In the last 12 months, operating cash flow was -13.92M and capital expenditures 0.00, giving a free cash flow of -13.92M billion.
Operating Cash Flow-13.92M
Free Cash Flow-13.92M
Free Cash Flow per Share-1.87
Dividends & Yields
Pasithea Therapeutics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change-85.56%
50-Day Moving Average1.26
200-Day Moving Average2.89
Relative Strength Index (RSI)39.90
Average Volume (3m)12.22M
Important Dates
Pasithea Therapeutics Corp upcoming earnings date is Mar 30, 2022, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateMar 30, 2022
Ex-Dividend Date―
Financial Position
Pasithea Therapeutics Corp as a current ratio of 6.58, with Debt / Equity ratio of 0.00%
Current Ratio6.58
Quick Ratio6.58
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pasithea Therapeutics Corp has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pasithea Therapeutics Corp EV to EBITDA ratio is <0.01, with an EV/FCF ratio of <0.01.
EV to Sales0.00
EV to EBITDA<0.01
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
Pasithea Therapeutics Corp has $6.92M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$6.92M billion.
Cash & Marketable Securities$6.92M
Total Debt$0.00
Net Cash-$6.92M
Net Cash Per Share-$0.93
Tangible Book Value Per Share$13.48K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Pasithea Therapeutics Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―